Cargando…

Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life

BACKGROUND AND OBJECTIVES: The clinical progression of severe dementia frequently leads to situations where surrogate decision makers must quickly make choices about potentially burdensome treatments that offer limited clinical benefit. We examined whether the number of decision makers and their acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholas, Lauren Hersch, Halpern, Scott D, Weir, David R, Baum, Micah Y, Nolan, Marie, Gallo, Joseph, Langa, Kenneth M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533208/
https://www.ncbi.nlm.nih.gov/pubmed/37771715
http://dx.doi.org/10.1093/geroni/igad081
_version_ 1785112142857371648
author Nicholas, Lauren Hersch
Halpern, Scott D
Weir, David R
Baum, Micah Y
Nolan, Marie
Gallo, Joseph
Langa, Kenneth M
author_facet Nicholas, Lauren Hersch
Halpern, Scott D
Weir, David R
Baum, Micah Y
Nolan, Marie
Gallo, Joseph
Langa, Kenneth M
author_sort Nicholas, Lauren Hersch
collection PubMed
description BACKGROUND AND OBJECTIVES: The clinical progression of severe dementia frequently leads to situations where surrogate decision makers must quickly make choices about potentially burdensome treatments that offer limited clinical benefit. We examined whether the number of decision makers and their access to advance directives were related to treatment choice for patients with severe dementia in comparison to those with normal cognition. RESEARCH DESIGN AND METHODS: We retrospectively linked survey responses about end-of-life treatment decisions to Medicare claims for Health and Retirement Study respondents dying between 2002 and 2015 whose next-of-kin reported a need for surrogate decision making. We estimated multivariable logistic regression models to study measures of aggressive care in the last 6 months of life; in-hospital death, burdensome transfers, and burdensome treatments. RESULTS: Compared to patients who were cognitively normal near the end of life (n = 1 198), patients with severe dementia (n = 722) were less likely to experience burdensome treatments (18% [95% confidence interval {CI} 14–21] vs 32% [95% CI 29–35]), burdensome transfers (20% [95% CI 17–24] vs 30% [95% CI 27–33]), and in-hospital death (24% [95% CI 20–28] vs 30% [95% CI 26–33]) when surrogates were involved. Rates of burdensome treatments, transfers, or in-hospital death for decedents with severe dementia did not vary with single versus multiple decision makers or when decision makers were informed by advance directives. However, among decedents with normal cognition, a single decision maker informed by an advance directive was associated with the lowest rates of burdensome treatments and in-hospital death. DISCUSSION AND IMPLICATIONS: Surrogate decision makers made similar choices around end-of-life care for patients with severe dementia regardless of the number of decision makers and availability of advance directives. However, both advance directives and single decision makers were associated with less aggressive care for cognitively normal decedents.
format Online
Article
Text
id pubmed-10533208
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105332082023-09-28 Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life Nicholas, Lauren Hersch Halpern, Scott D Weir, David R Baum, Micah Y Nolan, Marie Gallo, Joseph Langa, Kenneth M Innov Aging Original Report BACKGROUND AND OBJECTIVES: The clinical progression of severe dementia frequently leads to situations where surrogate decision makers must quickly make choices about potentially burdensome treatments that offer limited clinical benefit. We examined whether the number of decision makers and their access to advance directives were related to treatment choice for patients with severe dementia in comparison to those with normal cognition. RESEARCH DESIGN AND METHODS: We retrospectively linked survey responses about end-of-life treatment decisions to Medicare claims for Health and Retirement Study respondents dying between 2002 and 2015 whose next-of-kin reported a need for surrogate decision making. We estimated multivariable logistic regression models to study measures of aggressive care in the last 6 months of life; in-hospital death, burdensome transfers, and burdensome treatments. RESULTS: Compared to patients who were cognitively normal near the end of life (n = 1 198), patients with severe dementia (n = 722) were less likely to experience burdensome treatments (18% [95% confidence interval {CI} 14–21] vs 32% [95% CI 29–35]), burdensome transfers (20% [95% CI 17–24] vs 30% [95% CI 27–33]), and in-hospital death (24% [95% CI 20–28] vs 30% [95% CI 26–33]) when surrogates were involved. Rates of burdensome treatments, transfers, or in-hospital death for decedents with severe dementia did not vary with single versus multiple decision makers or when decision makers were informed by advance directives. However, among decedents with normal cognition, a single decision maker informed by an advance directive was associated with the lowest rates of burdensome treatments and in-hospital death. DISCUSSION AND IMPLICATIONS: Surrogate decision makers made similar choices around end-of-life care for patients with severe dementia regardless of the number of decision makers and availability of advance directives. However, both advance directives and single decision makers were associated with less aggressive care for cognitively normal decedents. Oxford University Press 2023-08-01 /pmc/articles/PMC10533208/ /pubmed/37771715 http://dx.doi.org/10.1093/geroni/igad081 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of The Gerontological Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Report
Nicholas, Lauren Hersch
Halpern, Scott D
Weir, David R
Baum, Micah Y
Nolan, Marie
Gallo, Joseph
Langa, Kenneth M
Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life
title Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life
title_full Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life
title_fullStr Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life
title_full_unstemmed Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life
title_short Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life
title_sort decision making for patients with severe dementia versus normal cognition near the end of life
topic Original Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533208/
https://www.ncbi.nlm.nih.gov/pubmed/37771715
http://dx.doi.org/10.1093/geroni/igad081
work_keys_str_mv AT nicholaslaurenhersch decisionmakingforpatientswithseveredementiaversusnormalcognitionneartheendoflife
AT halpernscottd decisionmakingforpatientswithseveredementiaversusnormalcognitionneartheendoflife
AT weirdavidr decisionmakingforpatientswithseveredementiaversusnormalcognitionneartheendoflife
AT baummicahy decisionmakingforpatientswithseveredementiaversusnormalcognitionneartheendoflife
AT nolanmarie decisionmakingforpatientswithseveredementiaversusnormalcognitionneartheendoflife
AT gallojoseph decisionmakingforpatientswithseveredementiaversusnormalcognitionneartheendoflife
AT langakennethm decisionmakingforpatientswithseveredementiaversusnormalcognitionneartheendoflife